Jackson Acquisition Company II
JACSFinancial ServicesNASDAQShell Companies · Last scanned Sep 9, 2026
Scan Results
Daily timeframeJackson Acquisition Company II does not have significant operations. Valued at $317.2M, JACS is a small-cap name in its sector. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry.
Market Cap
$317.2M
Beta
—
P/E (TTM)
36.97
P/E (Fwd)
—
EPS (TTM)
$0.29
EPS (Fwd)
—
ROE
—
ROA
—
Cash
$358,338
Total Debt
$198,024
Free CF
—
52W Change
3.6%
Annual Financials
Cash vs Debt
Where JACS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, JACS finished 1.32% above its 150-day moving average ($10.61) and 1.70% above its 200-day moving average ($10.57). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is JACS overbought or oversold?
At the September 3, 2026 close, JACS's RSI(14) was 50.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $358K in cash and $198K in debt, JACS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating.
As with any equity investment, JACS carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Jackson Acquisition Company II and its sector.